MedTrace Logo

Biological Therapy in Patients With Inflammatory Bowel Disease

NCT05599867 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2022-10-31

No results posted yet for this study

Summary

Inflammatory bowel disease (IBD) is characterised by chronic, relapsing inflammation of the intestinal mucosa and an inability to down regulate the inflammatory immune response once activated. IBD encompasses ulcerative colitis (UC), Crohn's disease (CD) and indeterminate colitis which is not clearly diagnosed as UC or CD. The peak age of onset of IBD is 15 to 30 years, with a second smaller peak occurring between 50 and 70 years of age

Conditions

  • Quality of Life

Interventions

BEHAVIORAL

quality of life

to assess quality among patients with patients with IBD

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Ahmed M Abu-Elfatth · Assiut University

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2023-11-30
Completion
2023-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05599867 on ClinicalTrials.gov